SCHEMBL279868

SCHEMBL279868

C1=CNSC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1979030 0.78
SCHEMBL17319732 0.68
SCHEMBL30804404 0.67
SCHEMBL27580360 0.67
SCHEMBL19171436 0.67
SCHEMBL515026 0.47
SCHEMBL5072565 0.40
SCHEMBL452580 0.40
Hydrogen Sulfide SCHEMBL28741033 0.38
Hydrogen Sulfide SCHEMBL29265424 0.38

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 651 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108929337-A A kind of preparation method of 4,5- thiazoline simultaneously [5,4-c] quinoline -2- amine 上海应用技术大学 2018-12-04 CN claimed
CN-108779116-A The inhibitor of Multiple Endocrine tumor albumen-MLL interactions 生命医药公司 2018-11-09 CN claimed
CN-103709085-B Pleuromulins microbiotic SHANDONG HENRY MEDICAL SCIENCE AND TECHNOLOGY CO., LTD. (CN) 2016-03-09 CN claimed
CN-103709102-B Containing whorled pleuromulins microbiotic SHANDONG HENRY MEDICAL SCIENCE AND TECHNOLOGY CO., LTD. (CN) 2015-08-12 CN claimed
CN-104513213-A Fxr agonist KBP BIOSCIENCES CO LTD 2015-04-15 CN claimed
CN-102783482-B 3-isothiazolinone composition DALIAN BIO-CHEM CO., LTD. (CN) 2014-10-22 CN claimed
CN-102783483-B 3-isothiazolinone composition DALIAN BIO CHEMICAL CO LTD 2014-07-16 CN claimed
CN-103709085-A Pleuromutilin antibiotics KBP BIOSCIENCES CO LTD 2014-04-09 CN claimed
CN-103709115-A Pleuromutilin antibiotic derivatives KBP BIOSCIENCES CO LTD 2014-04-09 CN claimed
CN-103709093-A Combined-ring-containing pleuromutilin antibiotics KBP BIOSCIENCES CO LTD 2014-04-09 CN claimed
US-20040152690-A1 Vanilloid receptor ligands and their use in treatments AMGEN INC. 2004-08-05 US claimed
US-20040082780-A1 Vanilloid receptor ligands and their use in treatments AMGEN, INC. 2004-04-29 US claimed
WO-2004035549-A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS VANILLOID RECEPTOR LIGANDS AMGEN INC. (US) 2004-04-29 WO claimed
US-20040038969-A1 Vanilloid receptor ligands and their use in treatments AMGEN, INC. 2004-02-26 US claimed
WO-2004014871-A1 VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS AMGEN INC. (US) 2004-02-19 WO claimed
WO-2004011417-A1 N-BISARYL- AND N-ARYL-CYCLOALKYLIDENYL-ALPHA-HYDROXY-AND ALPHA-ALKOXY ACID AMIDES SYNGENTA PARTICIPATIONS AG (CH) 2004-02-05 WO claimed
WO-2003099284-A1 AMINO-PYRIDINE, -PYRIDINE AND PYRIDAZINE DERIVATIVES FOR USE AS VANILLOID RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN AMGEN INC. (US) 2003-12-04 WO claimed
US-20030195201-A1 Vanilloid receptor ligands and their use in treatments AMGEN INC. 2003-10-16 US claimed
WO-2003049702-A2 VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS AMGEN INC. (US) 2003-06-19 WO claimed
CN-1253554-A Heterocyclic compounds and their use for inhibiting 'beta'-amyloid peptide ELAN MEDICINE CO (US) 2000-05-17 CN claimed